23-Mar-2026
Wells Fargo Remains a Buy on Veeva Systems (VEEV)
TipRanks (Thu, 19-Mar 7:10 AM ET)
Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences
PRNewswire (Tue, 10-Mar 11:45 AM ET)
AOP Health Standardizes on Veeva Industry Cloud for Life Sciences Across All Business Areas
PRNewswire (Tue, 10-Mar 9:01 AM ET)
Veeva Announces Fourth Quarter and Fiscal Year 2026 Results
PRNewswire (Wed, 4-Mar 4:05 PM ET)
PRNewswire (Tue, 3-Mar 7:03 AM ET)
Veeva to Release Fiscal 2026 Fourth Quarter and Full Year Results on March 4, 2026
PRNewswire (Wed, 11-Feb 4:05 PM ET)
13 of the Top 20 Biopharmas Standardize Globally on Veeva Link Key People
PRNewswire (Wed, 4-Feb 7:03 AM ET)
PRNewswire (Thu, 29-Jan 8:00 AM ET)
Industry Research Finds Establishing a Foundation for AI is Top Priority for CPG Enterprises
PRNewswire (Tue, 27-Jan 7:03 AM ET)
Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
PRNewswire (Thu, 8-Jan 4:05 PM ET)
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Veeva Systems Class A trades on the NYSE stock market under the symbol VEEV.
As of March 23, 2026, VEEV stock price climbed to $185.23 with 1,326,859 million shares trading.
VEEV has a beta of 1.07, meaning it tends to be more sensitive to market movements. VEEV has a correlation of 0.20 to the broad based SPY ETF.
VEEV has a market cap of $30.45 billion. This is considered a Large Cap stock.
Last quarter Veeva Systems Class A reported $836 million in Revenue and $2.06 earnings per share. This beat revenue expectation by $26 million and exceeded earnings estimates by $.35.
In the last 3 years, VEEV traded as high as $310.50 and as low as $160.21.
The top ETF exchange traded funds that VEEV belongs to (by Net Assets): VTI, VO, VUG, VXF, VOT.
VEEV has underperformed the market in the last year with a price return of -21.5% while the SPY ETF gained +17.9%. VEEV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -16.5% and -5.2%, respectively, while the SPY returned -3.4% and -2.3%, respectively.
VEEV support price is $179.43 and resistance is $188.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VEEV shares will trade within this expected range on the day.